#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5125545	Binding	Inhibition of SETD2 (1434 to 1711 residues) (unknown origin) using SAM and biotin-Ahx-RKSAPATGGVKKPHR-NH2 as substrate preincubated for 30 mins followed by substrate addition by topcount scintillation counting method	Homo sapiens	10	ALA5120931	single protein format	Scientific Literature
2.	ALA5125546	Binding	Inhibition of SETD2 in human A549 cells assessed as reduction in H3K36me3 incubated for 3 days by in-cell western assay	Homo sapiens	10	ALA5120931	cell-based format	Scientific Literature
3.	ALA5125547	Functional	Antiproliferative activity against human KMS-34 cells assessed as reduction in cell viability incubated for 14 days by CellTiter-glo luminescence assay	Homo sapiens	10	ALA5120931	cell-based format	Scientific Literature
4.	ALA5125548	ADME	Apparent permeability across apical to basal side in human Caco-2 cells at 5 uM measured after 2 hrs by LC-MS/MS analysis	Homo sapiens	6	ALA5120931	cell-based format	Scientific Literature
5.	ALA5125549	ADME	Apparent permeability across basal to apical side in human Caco-2 cells at 5 uM measured after 2 hrs by LC-MS/MS analysis	Homo sapiens	6	ALA5120931	cell-based format	Scientific Literature
6.	ALA5125550	ADME	Stability in human hepatocytes assessed as intrinsic clearance at 0.5 uM measured after 120 mins by LC/MS/MS analysis	Homo sapiens	6	ALA5120931	cell-based format	Scientific Literature
7.	ALA5125551	ADME	Stability in rat hepatocytes assessed as intrinsic clearance at 0.5 uM measured after 60 mins by LC/MS/MS analysis	Rattus norvegicus	6	ALA5120931	cell-based format	Scientific Literature
8.	ALA5125552	ADME	Stability in mouse hepatocytes assessed as intrinsic clearance at 0.5 uM measured after 60 mins by LC/MS/MS analysis	Mus musculus	6	ALA5120931	cell-based format	Scientific Literature
9.	ALA5125570	ADME	Clearance in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5120931	organism-based format	Scientific Literature
10.	ALA5125571	ADME	Volume of distribution at steady state in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5120931	organism-based format	Scientific Literature
11.	ALA5125572	ADME	AUC in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5120931	organism-based format	Scientific Literature
12.	ALA5125573	ADME	Half life in CD-1 IGS mouse at 2 mg/kg, iv by LC-MS/MS analysis	Mus musculus	2	ALA5120931	organism-based format	Scientific Literature
13.	ALA5125578	ADME	Cmax in CD-1 IGS mouse at 50 mg/kg, po by LC-MS/MS analysis	Mus musculus	3	ALA5120931	organism-based format	Scientific Literature
14.	ALA5125579	ADME	AUC in CD-1 IGS mouse at 50 mg/kg, po by LC-MS/MS analysis	Mus musculus	3	ALA5120931	organism-based format	Scientific Literature
15.	ALA5125580	ADME	Half life in CD-1 IGS mouse at 50 mg/kg, po by LC-MS/MS analysis	Mus musculus	3	ALA5120931	organism-based format	Scientific Literature
16.	ALA5125581	ADME	Oral bioavailability in CD-1 IGS mouse at 50 mg/kg by LC-MS/MS analysis	Mus musculus	3	ALA5120931	organism-based format	Scientific Literature
17.	ALA5125582	ADME	Clearance in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	2	ALA5120931	organism-based format	Scientific Literature
18.	ALA5125583	ADME	Volume of distribution in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	2	ALA5120931	organism-based format	Scientific Literature
19.	ALA5125584	ADME	AUC in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	2	ALA5120931	organism-based format	Scientific Literature
20.	ALA5125585	ADME	Half life in Sprague-Dawley rat at 2 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	2	ALA5120931	organism-based format	Scientific Literature